Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 05, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. ("PAD" or the "Company"), a high-growth aerospace and defense engineering and manufacturing company, today announced its entry into a non-binding Letter of Intent to acquire a leading provider of telecommunications equipment, surveillance systems, and structural steel fabrication defense applications ("Target"). The announcement follows the Company's previously disclosed proposed business combination with FACT II Acquisition Corp. ("FACT") (NASDAQ:FACT), a special purpose acquisition co
Overland Park, KS and New York, NY, May 19, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. ("PAD"), a high-growth aerospace & defense engineering and manufacturing company, and FACT II Acquisition Corp. ("FACT") (NASDAQ:FACT), a special purpose acquisition company, today announced that they have publicly filed an amended registration statement on Form S‑4 with the U.S. Securities and Exchange Commission (the "SEC") in connection with their proposed business combination (the "Business Combination"). The amended filing includes updated financial information and additional material information related to the proposed transaction announced on December 1, 2025. Transaction
Precision Aerospace & Defense Group, Inc. ("PAD"), a high-growth aerospace & defense engineering and manufacturing company, and FACT II Acquisition Corp. ("FACT") (NASDAQ:FACT), a special purpose acquisition company, today announced that they have publicly filed an amended registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the "SEC") in connection with their proposed business combination (the "Business Combination"). The amended filing includes updated financial information and additional disclosures relating to the proposed transaction first announced on December 1, 2025. PAD has built a diversified platform spanning engineering & sustainment, precision
3/A - FACT II Acquisition Corp. (0002028935) (Issuer)
3 - FACT II Acquisition Corp. (0002028935) (Issuer)
3 - FACT II Acquisition Corp. (0002028935) (Issuer)
425 - FACT II Acquisition Corp. (0002028935) (Subject)
S-4/A - FACT II Acquisition Corp. (0002028935) (Filer)
SCHEDULE 13G/A - FACT II Acquisition Corp. (0002028935) (Subject)
Complete Solaria has entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE:FACT) ("Freedom"). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker "CSLR". Complete Solaria brings together two highly complementary businesses in a vertically integrated manufacturing and distribution model, delivering end to end residential solar solutions, world-class customer service, aesthetically appealing, high-performance solar panels, as well as project financing, design and software solutions, to the U.S.A and beyond. Complete
Complete Solaria, Inc. ("Complete Solaria" or the "Company"), a leading solar technology, services, and installation company, today announced that Brian Wuebbels has been named Chief Financial Officer, effective February 1, 2023. Wuebbels brings more than 20 years of financial and executive experience, having served as CFO and in senior leadership positions for public and private solar and industrial companies throughout his career, including companies such NIDEC, GCL Solar Materials, SunEdison, Honeywell, and General Electric. "I am pleased to welcome Brian to our leadership team," said Will Anderson, Complete Solaria CEO. "Brian's deep and extensive public and private company experience
SAN CARLOS, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced the appointment of Francis Sarena as Chief Operating Officer. Mr. Sarena will be responsible for leading strategic operations, driving business development, overseeing finance and investor relations and optimizing organizational functions. "We are thrilled to welcome Francis, an accomplished industry veteran, during this important phase of Apexigen's evolution," said Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer of Apexigen. "His deep biopharmaceut
SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)
SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)
SC 13G - Complete Solaria, Inc. (0001838987) (Subject)